Partner-reported
Partner sends us their current cash-pay and insurance-pathway prices via a structured monthly form.
Loading content…
Affiliate-supportedIndependent editorialWe never sell medicationSee how
Methodology
No black box. Here's the rubric, the cadence, and the conflict-of-interest controls — written down so we can be held to them.
A weighted average of 5 dimensions. Each dimension scores 0–10. The composite is normalized to 0–10 and shown on every provider card.
Price
Cash-pay + insurance pathway transparency
30%
FDA / regulatory status
Brand vs compounded; state licensing
20%
Customer experience
Cancellation friction, refunds, support
20%
Shipping speed
Time from intake to first dose
15%
Clinical depth
Provider credentials + visit modality
15%
Comparison tables surface up-to-two badges per provider. Every badge is programmatically derived from real data — never manually assigned, never influenced by affiliate commission. A badge that doesn't meet its criteria simply doesn't render, so we never display “Best for X” when we lack the data to back it.
editors_pickHighest GLP1Zoom score (≥ 7.0) among providers that pass all quality gates: verified pricing, no FDA warning letters, not defunct, and either accepts insurance OR starts under $250/mo. One winner per comparison.
lowest_costSingle cheapest monthly starting price in the comparison. Derived directly from monthlyStartingPrice; awarded to one row only.
best_for_cashCheapest provider that does NOT require insurance. Awarded to one row only, and not stacked with Lowest cost on the same row.
best_for_insuranceAccepts insurance via a verification flow AND starts under $100/mo. Multiple providers can qualify.
best_for_diabetesOffers at least one FDA-approved T2D-indicated GLP-1 (Ozempic, Mounjaro, Trulicity, Rybelsus, Victoza, Bydureon, Byetta). Hidden when the data on what the provider actually stocks is missing.
best_for_weight_lossOffers at least one FDA-approved obesity-indicated GLP-1 (Wegovy, Zepbound, Saxenda).
most_reviewedHighest verified-review count (Google or equivalent) in the comparison, and only when the leader has >100 reviews to avoid trivial leaders.
fastest_responseAverage provider response within 24 hours of intake. Multiple providers can qualify.
fda_approved_brandDispenses only FDA-approved brand-name GLP-1 medications (regulatoryStatus = fda_brand) AND has no active FDA warning letter.
Disclosure: GLP1Zoom earns a commission when a reader signs up with a partner through one of our links. Commission rate, partnership tier, and recency of payout have no input into the score or badge assignment. See affiliate disclosure.
Every partner price displayed on GLP1Zoom is verified through one of three channels, with timestamps shown via “Verified Xd ago” badges.
Partner sends us their current cash-pay and insurance-pathway prices via a structured monthly form.
An editorial reviewer signs up for the partner's intake (without completing payment) once per month to verify displayed price.
Users who see a discrepancy email editorial@; we re-verify within 48 hours and update or remove the listing.
Editor drafts content using FDA prescribing information + peer-reviewed sources.
Domain reviewer (MD / PharmD / RD / JD) cross-checks claims line-by-line.
Editor revises; reviewer re-approves.
Page publishes with a "Last reviewed" timestamp and reviewer name visible.
Re-review triggered by: FDA label update, new trial publication, partner change, or 6-month sweep — whichever comes first.
Headline prices ("from $99/mo") hide the actual long-term spend on a telehealth GLP-1 subscription. The true-cost calculator surfaces four hidden cost drivers: dose-escalation surcharges, commitment minimums, first-month discount cliffs, and permanent add-on fees.
We model standard titration — dose ramps from the starting milligram to target over the months planned. For providers that charge an escalation surcharge (e.g., Henry Meds +$100/tier above 1mg semaglutide), the fee is applied at each tier the user crosses. Eden, Embody Flat, and CallOnDoc are flat-priced and so escalation = $0.
Each provider publishes a discount % for 3/6/12-month upfront commits. We apply that discount only to the base medication cost, not to membership or labs, since membership is typically billed monthly regardless of plan tenure. When a provider does not publish a discount, we hold the discount at 0% and label the difference as TBD.
Henry Meds — henrymeds.com
+$100/dose-tier above 1mg semaglutide — disclosed only in FAQ
Eden — www.tryeden.com
Flat pricing regardless of dose
Mochi Health — joinmochi.com
$79/mo membership permanent + per-script fee
CallOnDoc — www.callondoc.com
Pricing hidden until visit started
WW Med+ — www.weightwatchers.com
$25 first 2 months → $74/mo membership
Hims — www.hims.com
$39 first month → $149+ ongoing
Ro — ro.co
Brand-name + insurance routing
Noom Med — www.noom.com
Med + behavioral bundle ($70/mo Noom)
Update cadence: quarterly review of every provider pricing page, plus ad-hoc updates when the price-change watchdog flags a delta. When a provider does not publicly disclose a fee, we label it "TBD per provider" rather than guess. Compounded GLP-1 medications are not FDA-approved as finished products — surfaced on every compounded provider card.
Editorial policy
Sources, cadence, AI policy →
Affiliate disclosure
FTC §255 commission flow →
Medical Review Board
Reviewer credentials →
See a flaw in the methodology? Want to suggest a different weighting? Tell us — we publish methodology updates with the date of change.